Ingevity Corporation $NGVT Shares Bought by SG Americas Securities LLC

SG Americas Securities LLC grew its position in shares of Ingevity Corporation (NYSE:NGVT) by 115.8% in the first quarter, Holdings Channel reports. The institutional investor owned 18,595 shares of the company’s stock after buying an additional 9,980 shares during the period. SG Americas Securities LLC’s holdings in Ingevity were worth $1,325,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Evolve Private Wealth LLC boosted its holdings in shares of Ingevity by 10.2% in the first quarter. Evolve Private Wealth LLC now owns 5,946 shares of the company’s stock valued at $424,000 after acquiring an additional 549 shares in the last quarter. Rockefeller Capital Management L.P. raised its holdings in Ingevity by 3,998.1% during the fourth quarter. Rockefeller Capital Management L.P. now owns 94,830 shares of the company’s stock worth $5,612,000 after purchasing an additional 92,516 shares in the last quarter. Pacer Advisors Inc. purchased a new position in Ingevity during the fourth quarter worth about $9,660,000. State of Tennessee Department of Treasury lifted its position in Ingevity by 25.3% in the fourth quarter. State of Tennessee Department of Treasury now owns 20,881 shares of the company’s stock valued at $1,236,000 after purchasing an additional 4,219 shares during the period. Finally, XTX Topco Ltd lifted its position in Ingevity by 409.3% in the fourth quarter. XTX Topco Ltd now owns 21,075 shares of the company’s stock valued at $1,247,000 after purchasing an additional 16,937 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Insider Transactions at Ingevity

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.88% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on NGVT. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a report on Tuesday, April 21st. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a report on Monday, June 29th. Two investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $80.00.

Ingevity Stock Performance

NYSE:NGVT opened at $72.28 on Friday. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. Ingevity Corporation has a fifty-two week low of $39.74 and a fifty-two week high of $79.29. The stock has a market cap of $2.51 billion, a PE ratio of -20.36 and a beta of 1.16. The firm’s fifty day simple moving average is $71.23 and its 200-day simple moving average is $69.10.

Ingevity (NYSE:NGVT) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.84 by $0.31. The firm had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.01 earnings per share. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. Analysts expect that Ingevity Corporation will post 5.05 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.